Fresenius Medical Care has filed a patent for a system and method to generate simulated dialysis treatment files. The system involves a dialysis treatment machine, an external device, and a simulation server. The server receives an existing dialysis treatment file, obtains patient and prescription information for a simulated treatment, modifies the existing information, and generates a new dialysis treatment file. The file is then sent to the external device, which stores it and can be used to display simulated results of the treatment. GlobalData’s report on Fresenius Medical Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

According to GlobalData’s company profile on Fresenius Medical Care, Remote monitored dialysis machines was a key innovation area identified from patents. Fresenius Medical Care's grant share as of September 2023 was 52%. Grant share is based on the ratio of number of grants to total number of patents.

Simulated dialysis treatment file generation and testing system

Source: United States Patent and Trademark Office (USPTO). Credit: Fresenius Medical Care AG & Co KGaA

A recently filed patent (Publication Number: US20230310724A1) describes a system and method for simulating dialysis treatments. The system includes a dialysis treatment machine, an external device, and a simulation server. The dialysis treatment machine is used to perform dialysis treatments for actual patients, while the external device stores dialysis treatment files. The simulation server receives an existing dialysis treatment file associated with a specific patient and modifies it to generate a modified dialysis treatment file for a simulated patient. This modified file includes information about the stages of the simulated treatment, alarms that occurred, and simulated user interactions. The simulation server then sends the modified dialysis treatment file to the external device.

The external device, which can be a patient card reader, stores the dialysis treatment file received from the simulation server. A dialysis treatment file computing device retrieves the file from the external device and inputs it into a dialysis treatment application. This application converts the file into a user interface that displays simulated results of the dialysis treatment. The user interface provides valuable information for healthcare professionals to analyze and evaluate the simulated treatment.

The method described in the patent involves obtaining patient information, dialysis prescription information, and dialysis treatment information for a simulated dialysis treatment. Based on this information, a dialysis treatment file is generated in a data format compatible with a dialysis treatment application. The file is then stored in an external device and retrieved by a computing device. The computing device inputs the file into the dialysis treatment application, which converts it into a user interface displaying simulated results of the treatment.

The dialysis treatment information in the generated file includes details about the stages of the simulated treatment, alarms that occurred, simulated user interactions, and statistics associated with the treatment. The dialysis prescription information indicates the specific prescription for the simulated patient, while the patient information indicates the type of dialysis device used for the simulated treatment.

Overall, this patent describes a system and method that allows for the simulation of dialysis treatments. By generating modified dialysis treatment files and converting them into user interfaces, healthcare professionals can analyze and evaluate the simulated treatments, providing valuable insights for improving patient care and treatment outcomes.

To know more about GlobalData’s detailed insights on Fresenius Medical Care, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies